BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.


Perini G. F., Owen C., Ozcan M., Jurczak W., Barca E. G., Wrobel T., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.41, sa.16, 2023 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 41 Sayı: 16
  • Basım Tarihi: 2023
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
  • Ankara Üniversitesi Adresli: Evet